Shining the soothing light

2013-10-21

(Press-News.org) Contact information: Heliton Spindola Antunes
hspindola@inca.gov.br
55-213-207-6597
Publicase Comunicação Científica
Shining the soothing light Almost all patients suffering from head and neck squamous cell carcinoma (HNSCC) develop canker sores, a complication resulting from different modalities of treatment, namely stem cell transplantation, chemotherapy, and radiotherapy. Canker sore is divided in five grades (zero to four) by the World Health Organization (WHO), with severe cases (grades 3 and 4) being associated with pain, weight loss, poor quality of life, and higher hospital costs due to increased healthcare needs. Severe canker sore can also lead to treatment interruption, which may decrease the patient's chances of surviving the cancer.

No effective preventative strategy is currently available for canker sore, but prospective trials of low-level laser therapy (LLLT) done in HNSCC patients undergoing chemoradiotherapy showed promising results. However, additional trials detected a high incidence of canker sore among patients, leaving the question of whether LLLT can effectively prevent canker sore still open.

Now, a group of scientists led by Dr. Heliton Spindola Antunes at the National Cancer Institute (INCA) in Rio de Janeiro, Brazil, has successfully performed a definitive trial showing that LLLT reduces the occurrence of canker sore in HNSCC patients undergoing concurrent chemoradiotherapy and improves patient's quality of life.

The trial was performed with 94 HNSCC patients undergoing chemoradiotherapy. They were divided into two groups of 47 individuals, one of which received LLLT while the other received placebo. Researchers observed a significant difference in the incidence of canker sore grades 3 and 4 between groups. For instance, while in the group of patients receiving LLLT only three patients developed severe cases of canker sore, in the group receiving the placebo this number was 19. There were also significant differences in the absence of canker sore (grades 0-1), with the LLLT group having 59.6% of patients free of canker sore as opposed to 21.3% in the placebo group. The LLLT group had less severe oral pain and, as a result, used fewer opioid analgesics. They were also less likely to require gastrostomy (a surgical opening into the stomach for nutritional support) throughout the cancer treatment.

"For ethical reasons," says Dr Antunes, "all patients who developed canker sore grades 3 or 4 in the placebo arm were then offered the option of receiving LLLT. They all improved to grade 2 or lower, supporting the evidence that LLLT is an effective choice to prevent or treat canker sore in these patients."

### The article entitled "Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck patients treated with concurrent chemoradiation" has been published ahead of print in Radiotherapy & Oncology and is available at http://dx.doi.org/10.1016/j.radonc.2013.08.010

ELSE PRESS RELEASES FROM THIS DATE:

NTU scientists make breakthrough solar technology

2013-10-21

NTU scientists make breakthrough solar technology Unique material is far cheaper to produce and generates almost as much power as today's thin film solar cells In the near future, solar panels will not only be more efficient but also a lot cheaper and affordable ...

Topological light: Living on the edge

2013-10-21

Topological light: Living on the edge Topology -- the understanding of how things are connected -- remains abstract, even with the popular example of doughnuts and coffee cups. This concept, esoteric as it appears, is also neat because it is the basis for creating ultrastable ...

New nanopharmaceutical may help overcome resistance to certain anticancer drugs

2013-10-21

New nanopharmaceutical may help overcome resistance to certain anticancer drugs BOSTON — The nanopharmaceutical drug CRLX101 is showing promise as a potential new treatment for cancers that develop resistance to antiangiogenic drugs and radiation ...

Antibody-drug conjugate may provide new treatment option for pancreatic cancer patients

2013-10-21

Antibody-drug conjugate may provide new treatment option for pancreatic cancer patients BOSTON — Patients with pancreatic cancer may benefit from an investigational member of an emerging class of anticancer drugs called antibody-drug conjugates, ...

New drug combinations may benefit patients with pancreatic cancer

2013-10-21

New drug combinations may benefit patients with pancreatic cancer BOSTON — Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may ...

Tuberculosis and the social lives of badgers

2013-10-21

Tuberculosis and the social lives of badgers Badgers are an important wildlife reservoir for tuberculosis infection, a disease that leads thousands of cattle to slaughter each year. Now, researchers reporting in the Cell Press journal Current Biology on October 21 have found ...

Traffic-related air pollution a substantial public health concern

2013-10-21

Traffic-related air pollution a substantial public health concern Traffic-related air pollution is increasingly shown to have negative health effects according to a growing body of epidemiologic evidence and is a substantial public health concern ...

Infection connections: Badger surveillance project reveals how TB infects their social networks

2013-10-21

Infection connections: Badger surveillance project reveals how TB infects their social networks Researchers at the University of Exeter and the AHVLA's National Wildlife Management Centre have shown that the social lives of badgers are related to their risk of infection ...

Hair regeneration method is first to induce new human hair growth

2013-10-21

Hair regeneration method is first to induce new human hair growth Technique uses a patient's own cells to grow new hair NEW YORK, NY (October, 21, 2013) — Researchers at Columbia University Medical Center (CUMC) have devised a hair restoration method ...

CWRU makes nanodiamonds in ambient conditions

2013-10-21

CWRU makes nanodiamonds in ambient conditions Opens door for flexible electronics, implants and more CLEVELAND--Instead of having to use tons of crushing force and volcanic heat to forge diamonds, researchers at Case Western Reserve University have ...